Inogen, Inc.

Inogen, Inc.

INGN·NASDAQ

$6.31

+3.9%
HealthcareMedical - Devices

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

At a Glance

Live Snapshot
Market Cap$170.84M
EPS-0.8500
P/E Ratio-7.42
Earnings Date08/06/2026

ingn

Capital Lease Obligations

Last Annual Value

14.31M

3-Year CAGR

-15%

5-Year CAGR

7%

10-Year CAGR

%

Inogen, Inc.

Inogen, Inc. Competitors Analysis of Capital Lease Obligations

INGN · NASDAQ
CompanyCapital Lease Obligations
CAGR 3Y
CAGR 5Y
CAGR 10Y
INGN logo
Inogen, Inc.
NASDAQ:INGN
14.31M
-13.2%-11.7%N/A 
0.00
N/AN/AN/A
CVRX logo
CVRx, Inc.
NASDAQ:CVRX
638.00K
-22.9%N/AN/A
0.00
N/AN/AN/A
457.00K
-20.4%-5.6%N/A
198.00K
34.7%29.7%58.3%
0.00
N/AN/AN/A
37.24M
-3.5%12.7%N/A
14.21M
-12.3%-9.7%N/A
3.27M
-18.6%-16.5%N/A
854.00K
20.2%17.2%N/A
Inogen, Inc.

Inogen, Inc. Fair Value Envelope

INGN · NASDAQ

Our analysis suggests that INGN has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $6.31, this represents a potential HIDDEN relative to our calculated worth for Inogen, Inc..

Intrinsic Value
Current Price: $6.31